Literature DB >> 11584068

Re: Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 Randomized Trial.

J R Benson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11584068     DOI: 10.1093/jnci/93.19.1493

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  2 in total

1.  Selenophenes: Introducing a New Element into the Core of Non-Steroidal Estrogen Receptor Ligands.

Authors:  Silong Zhang; Zhiyong Wang; Zhiye Hu; Changhao Li; Chu Tang; Kathryn E Carlson; Junjie Luo; Chune Dong; John A Katzenellenbogen; Jian Huang; Hai-Bing Zhou
Journal:  ChemMedChem       Date:  2017-01-09       Impact factor: 3.466

2.  Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer.

Authors:  James J Dignam; Vanja Dukic; Stewart J Anderson; Eleftherios P Mamounas; D Lawrence Wickerham; Norman Wolmark
Journal:  Breast Cancer Res Treat       Date:  2008-10-02       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.